Identification of oligoclonal CD4 T cells in diffuse large B cell lymphomas

Clinical Immunology

Volumn 107, Issue 3, 2003, Pages 160-169

  Li, Hai ^a   Ma, Xun ^a   Moskovits, Tibor ^a   Inghirami, Giorgio ^a,b   Tsiagbe, Vincent K ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

B cell lymphoma; Human lymphoma; T cell receptor; Tumor immunity

Indexed keywords

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD; CLONE; CONTROLLED STUDY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELAPSE; T LYMPHOCYTE;

EID: 0038203057     PISSN: 15216616     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6616(03)00043-3     Document Type: Article

References (42)

1. Jacobson E.B., Caporale L.H., Thorbecke G.J. Effect of thymus cell injections on germinal center formation in lymphoid tissues of nude (thymusless) mice. Cell. Immunol. 13:1974;416-430.
2. Tsiagbe V.K., Thorbecke G.J. Overview of germinal center function and structure in normal and genetically enginereed mice. Thorbecke G.J., Tsiagbe V.K. The Biology of Germinal Centers in Lymphoid Tissue. 1998;1-103 Springer-Verlag, New York.
3. Martin I., Bonnefoix T., Roucard C., Perron P., Lajmanovich A., Moine A., Leroux D., Sotto J.J., Garban F. Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma aborted activation and G1 blockade induced by cell-cell contact . Eur. J. Immunol. 29:1999;3188-3195.
4. Lerman S.P., Carswell E.A., Chapman J., Thorbecke G.J. Properties of reticulum cell sarcomas in SJL/J mice. III. Promotion of tumor growth in irradiated mice by normal lymphoid cells. Cell. Immunol. 23:1976;53-67.
5. Carswell E.A., Lerman S.P., Thorbecke G.J. Properties of reticulum cell sarcomas in SJL/J mice. II. Fate of labeled tumor cells in normal and irradiated syngeneic mice. Cell. Immunol. 23:1976;39-52.
6. Alisauskas R.M., Ponzio N.M. T helper cell-specific monoclonal antibody inhibits progressive growth of B cell lymphomas in syngeneic SJL/J mice. Cell. Immunol. 119:1989;286-303.
7. Ponzio N.M., Thorbecke G.J. Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas. Semin. Cancer Biol. 10:2000;331-340.
8. Thorbecke G.J., Ponzio N.M. Reverse immune surveillance an adaptive mechanism used by tumor cells to facilitate their survival and growth . Semin. Cancer Biol. 10:2000;327-330.
9. Tsiagbe V.K., Asakawa J., Miranda A., Sutherland R.M., Paterson Y., Thorbecke G.J. Syngeneic response to SJL follicular center B cell lymphoma (reticular cell sarcoma) cells is primarily in V beta 16+ CD4+ T cells. J. Immunol. 150:1993;5519-5528.
10. Tsiagbe V.K., Yoshimoto T., Asakawa J., Cho S.Y., Meruelo D., Thorbecke G.J. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. EMBO J. 12:1993;2313-2320.
11. Zhang D.J., Tsiagbe V.K., Huang C., Thorbecke G.J. Control of endogenous mouse mammary tumor virus superantigen expression in SJL lymphomas by a promoter within the env region. J. Immunol. 157:1996;3510-3517.
12. Tsiagbe V.K., Ponzio N.M., Erianne G.S., Zhang D.J., Thorbecke G.J., Inghirami G. Germinal center derived lymphomas in humans and mice. Thorbecke G.J., Tsiagbe V.K. The Biology of Germinal Centers in Lymphoid Tissue. 1998;199-234 Springer-Verlag, New York.
13. Sen N., Simmons W.J., Thomas R.M., Erianne G., Zhang D.J., Jaeggli N.S., Huang C., Xiong X., Tsiagbe V.K., Ponzio N.M., et al. META-controlled env-initiated transcripts encoding superantigens of murine Mtv29 and Mtv7 and their possible role in B cell lymphomagenesis. J. Immunol. 166:2001;5422-5429.
14. Puisieux I., Even J., Pannetier C., Jotereau F., Favrot M., Kourilsky P. Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J. Immunol. 153:1994;2807-2818.
15. Monteiro J., Hingorani R., Choi I.H., Silver J., Pergolizzi R., Gregersen P.K. Oligoclonality in the human CD8+ T cell repertoire in normal subjects and monozygotic twins implications for studies of infectious and autoimmune diseases . Mol. Med. 1:1995;614-624.
16. Serrano D., Monteiro J., Allen S.L., Kolitz J., Schulman P., Lichtman S.M., Buchbinder A., Vinciguerra V.P., Chiorazzi N., Gregersen P.K. Clonal expansion within the CD4+CD57+ and CD8+CD57+ T cell subsets in chronic lymphocytic leukemia. J. Immunol. 158:1997;1482-1489.
17. Currier J.R., Yassai M., Robinson M.A., Gorski J. Molecular defects in TCRBV genes preclude thymic selection and limit the expressed TCR repertoire. J. Immunol. 157:1996;170-175.
18. Akolkar P.N., Gulwani-Akolkar B., Pergolizzi R., Bigler R.D., Silver J. Influence of HLA genes on T cell receptor V segment frequencies and expression levels in peripheral blood lymphocytes. J. Immunol. 150:1993;2761-2773.
19. Kronenberg M., Siu G., Hood L.E., Shastri N. The molecular genetics of the T-cell antigen receptor and T-cell antigen recognition. Annu. Rev. Immunol. 4:1986;529-591.
20. Hingorani R., Choi I.H., Akolkar P., Gulwani-Akolkar B., Pergolizzi R., Silver J., Gregersen P.K. Clonal predominance of T cell receptors within the CD8+ CD45RO+ subset in normal human subjects. J. Immunol. 151:1993;5762-5769.
21. Halapi E., Jeddi-Tehrani M., Blucher A., Andersson R., Rossi P., Wigzell H., Grunewald J. Diverse T-cell receptor CDR3 length patterns in human CD4+ and CD8+ T lymphocytes from newborns and adults. Scand. J. Immunol. 49:1999;149-154.
22. Morley J.K., Batliwalla F.M., Hingorani R., Gregersen P.K. Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. J. Immunol. 154:1995;6182-6190.
23. Shilyansky J., Nishimura M.I., Yannelli J.R., Kawakami Y., Jacknin L.S., Charmley P., Rosenberg S.A. T-cell receptor usage by melanoma-specific clonal and highly oligoclonal tumor-infiltrating lymphocyte lines. Proc. Natl. Acad. Sci. USA. 91:1994;2829-2833.
24. Goolsby C.L., Kuchnio M., Finn W.G., Peterson L. Expansions of clonal and oligoclonal T cells in B-cell chronic lymphocytic leukemia are primarily restricted to the CD3(+)CD8(+) T-cell population. Cytometry. 42:2000;188-195.
25. Subramanyam M., McLellan B., Labrecque N., Sekaly R.P., Huber B.T. Presentation of the Mls-1 superantigen by human HLA class II molecules to murine T cells. J. Immunol. 151:1993;2538-2545.
26. Schwab R., Szabo P., Manavalan J.S., Weksler M.E., Posnett D.N., Pannetier C., Kourilsky P., Even J. Expanded CD4+ and CD8+ T cell clones in elderly humans. J. Immunol. 158:1997;4493-4499.
27. Gulwani-Akolkar B., Akolkar P.N., McKinley M., Fisher S.E., Silver J. Crohn's disease is accompanied by changes in the CD4+, but not CD8+, T cell receptor BV repertoire of lamina propria lymphocytes. Clin. Immunol. Immunopathol. 77:1995;95-106.
28. Yurovsky V.V., Wigley F.M., Wise R.A., White B. Skewing of the CD8+ T-cell repertoire in the lungs of patients with systemic sclerosis. Hum. Immunol. 48:1996;84-97.
29. Rezvany M.R., Jeddi-Tehrani M., Osterborg A., Kimby E., Wigzell H., Mellstedt H. Oligoclonal TCRBV gene usage in B-cell chronic lymphocytic leukemia major perturbations are preferentially seen within the CD4 T-cell subset . Blood. 94:1999;1063-1069.
30. Fais F., Ghiotto F., Hashimoto S., Sellars B., Valetto A., Allen S.L., Schulman P., Vinciguerra V.P., Rai K., Rassenti L.Z., et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1998;1515-1525.
31. Pritsch O., Troussard X., Magnac C., Mauro F.R., Davi F., Payelle-Brogard B., Dumas G., Pulik M., Clerget F., Mandelli F., et al. VH gene usage by family members affected with chronic lymphocytic leukaemia. Br. J. Haematol. 107:1999;616-624.
32. Lasky J.L., Thorbecke G.J. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines. Eur. J. Immunol. 19:1989;365-371.
33. Schattner E.J. Cd40 Ligand in CII Pathogenesis and Therapy. Leukocyte Lymphoma. 37:2000;461-472.
34. Wang D., Freeman G.J., Levine H., Ritz J., Robertson M.J. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies. Br. J. Haematol. 97:1997;409-417.
35. La Mantia G., Maglione D., Pengue G., Di Cristofano A., Simeone A., Lanfrancone L., Lania L. Identification and characterization of novel human endogenous retroviral sequences prefentially expressed in undifferentiated embryonal carcinoma cells. Nucleic Acids Res. 19:1991;1513-1520.
36. Leib-Mosch C., Haltmeier M., Werner T., Geigl E.M., Brack-Werner R., Francke U., Erfle V., Hehlmann R. Genomic distribution and transcription of solitary HERV-LTRs. Genomics. 18:1993;261.
37. Indraccolo S., Gunzburg W.H., Leib-Mosch C., Erfle V., Salmons B. Identification of three human sequences with viral superantigen-specific primers. Mamm. Genome. 6:1995;339-344.
38. Liu B., Wang Y., Melana S.M., Pelisson I., Najfeld V., Holland J.F., Pogo B.G. Identification of a proviral structure in human breast cancer. Cancer Res. 61:2001;1754-1759.
39. Wilkinson D.A., Mager D.L., Leong J.C. Endogenous human retroviruses. Levy J. The Retroviridae. 1994;465-535 Plenum, New York.
40. Wang Y., Holland J.F., Bleiweiss I.J., Melana S., Liu X., Pelisson I., Cantarella A., Stellrecht K., Mani S., Pogo B.G. Detection of mammary tumor virus env gene-like sequences in human breast cancer. Cancer Res. 55:1995;5173-5179.
41. Etkind P., Du J., Khan A., Pillitteri J., Wiernik P.H. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient [In Process Citation]. Clin. Cancer Res. 6:2000;1273-1278.
42. Jones N., Leiden J., Dialynas D., Fraser J., Clabby M., Kishimoto T., Strominger J.L., Andrews D., Lane W., Woody J. Partial primary structure of the alpha and beta chains of human tumor T-cell receptors. Science. 227:1985;311-314.